Dr. MartensDOCMF 53 Debt-to-EBITDA is 2.21 as of Mar. 2026, which is 16% above its 10-year median of 1.90. GuruFocus rates DOCMF with a GF Score™ of 53/100 and a GF Value™ of $0.97 (Fairly Valued). The stock has 3 warning signs investors should review. Among 810 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks worse than 55.56% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Dr. Martens's Debt-to-EBITDA or its related term are showing as below:
DOCMF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.96 Med: 1.9 Max: 3.66
Current: 3.08
During the past 9 years, the highest Debt-to-EBITDA Ratio of Dr. Martens was 3.66. The lowest was 0.96. And the median was 1.90.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Dr. Martens Debt-to-EBITDA Related Terms
Dr. Martens Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Dr. Martens's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOCMF vs NKE, DECK, ONON: Debt-to-EBITDA Comparison
For the Footwear & Accessories subindustry, Dr. Martens's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens Debt-to-EBITDA vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Dr. Martens's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Mar. 2026) EBITDA data.
Dr. Martens (DOCMF) has a Debt-to-EBITDA of 2.21 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Dr. Martens. This is 16% above median its historical median of 1.90. Over the past decade, Dr. Martens' Debt-to-EBITDA has ranged from 0.96 to 3.66. According to the industry distribution chart, Dr. Martens ranks #450 out of 810 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 55.6%.
Is Dr. Martens' Debt-to-EBITDA too high?
Dr. Martens' current Debt-to-EBITDA of 2.21 is 16% above median its 10-year median of 1.90. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 3.66. The Manufacturing - Apparel & Accessories industry median Debt-to-EBITDA is 2.72. Dr. Martens' value of 2.21 is 18.8% below this industry median. Based on the distribution chart, Dr. Martens ranks #450 out of 810 companies in the Manufacturing - Apparel & Accessories industry, which is below the industry midpoint. Overall, Dr. Martens has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Debt-to-EBITDA compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #450 out of 810 companies for Debt-to-EBITDA. This places Dr. Martens in the lower half of its industry. The industry median Debt-to-EBITDA is 2.72. Dr. Martens' value of 2.21 is 18.8% below this benchmark. Historically, Dr. Martens' own Debt-to-EBITDA has ranged from 0.96 to 3.66 over the past decade. While the company's 10-year median is 1.90 vs. the industry median of 2.72, Dr. Martens has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Manufacturing - Apparel & Accessories company?
The median Debt-to-EBITDA among Manufacturing - Apparel & Accessories companies is 2.72, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Martens's current Debt-to-EBITDA of 2.21 is 18.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Dr. Martens. For the Manufacturing - Apparel & Accessories industry, the median Debt-to-EBITDA is 2.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current Debt-to-EBITDA is 2.21, which is 16% above median its own 10-year median of 1.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Fairly Valued. The stock's GF Value™ is $0.97, compared to a current price of $0.97 — trading right at its estimated fair value. The current Debt-to-EBITDA is 2.21, which is 16% above median its 10-year median of 1.90 and 18.8% below the Manufacturing - Apparel & Accessories industry median of 2.72. Dr. Martens' overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current Debt-to-EBITDA is 2.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DOCMF) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued.
The current stock price of $0.97 is trading 0% below its estimated GF Value™ of $0.97.
GuruFocus considers Dr. Martens to be Fairly Valued.
Key valuation signals for DOCMF:
Debt-to-EBITDA: 2.21 (16% above median its 10-year median of 1.90)
GF Value™: $0.97 vs. price of $0.97 (0% below fair value)
Industry Position: 18.8% below the Manufacturing - Apparel & Accessories median (#450 of 810)
No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
53GF Score
Get the complete analysis for DOCMF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCMF has been successfully added to your 
